Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrEP-LANA (Pre-exposure Prophylaxis- Long-acting Novel Antiviral Agent)

NCT07620730 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT07620730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07620730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrEP-LANA (Pre-exposure Prophylaxis- Long-acting Novel Antiviral Agent)
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
June 30, 2028
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

community setting, equity, prep, prep adherence experiences, prep adherence perspectives, prep uptake